These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8242995)

  • 1. Is there a role for corticosteroid prophylaxis in patients at increased risk of adverse reactions to intravascular contrast agents?
    Dawson P; Sidhu PS
    Clin Radiol; 1993 Oct; 48(4):225-6. PubMed ID: 8242995
    [No Abstract]   [Full Text] [Related]  

  • 2. Corticosteroid prophylaxis in patients at increased risk of adverse reactions to intravascular contrast agents.
    Lasser EC
    Clin Radiol; 1994 Aug; 49(8):582-3; author reply 583-4. PubMed ID: 7955878
    [No Abstract]   [Full Text] [Related]  

  • 3. Corticosteroid prophylaxis for patients with increased risk of adverse reactions to intravascular contrast agents.
    Lasser EC
    Clin Radiol; 1995 Jun; 50(6):423-4. PubMed ID: 7789035
    [No Abstract]   [Full Text] [Related]  

  • 4. Corticosteroid prophylaxis for patients receiving intravascular contrast agents: a survey of current practice in Australia and New Zealand.
    Bensusan D; Stevenson JD; Palmer FJ
    Australas Radiol; 1998 Feb; 42(1):25-7. PubMed ID: 9509599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Corticosteroid prophylaxis for contrast media reactions.
    Morcos SK
    Clin Radiol; 1994 Jul; 49(7):508; author reply 509-10. PubMed ID: 8088053
    [No Abstract]   [Full Text] [Related]  

  • 6. Corticosteroid prophylaxis for patients with increased risk of adverse reactions to intravascular contrast agents: a survey of current practice in the UK.
    Seymour R; Halpin SF; Hardman JA; Coote JM; Ruttley MS; Roberts GM
    Clin Radiol; 1994 Nov; 49(11):791-5. PubMed ID: 7955846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stratified premedication strategy for the prevention of contrast media hypersensitivity in high-risk patients.
    Lee SY; Yang MS; Choi YH; Park CM; Park HW; Cho SH; Kang HR
    Ann Allergy Asthma Immunol; 2017 Mar; 118(3):339-344.e1. PubMed ID: 28087383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Corticosteroid prophylaxis for contrast media reactions.
    Ansell G
    Clin Radiol; 1994 Jul; 49(7):508; author reply 509-10. PubMed ID: 8088052
    [No Abstract]   [Full Text] [Related]  

  • 9. The Evidence for and Against Corticosteroid Prophylaxis in At-Risk Patients.
    Davenport MS; Cohan RH
    Radiol Clin North Am; 2017 Mar; 55(2):413-421. PubMed ID: 28126223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Corticosteroid prophylaxis and contrast media.
    Ansell G
    Hosp Med; 1998 Mar; 59(3):249. PubMed ID: 9722358
    [No Abstract]   [Full Text] [Related]  

  • 11. [Prevention of intolerance to iodized contrast media ].
    Soyer P; Levesque M
    Presse Med; 1990 Mar; 19(12):562-5. PubMed ID: 2139217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Corticosteroid prophylaxis and contrast media.
    Morcos SK
    Hosp Med; 1998 Mar; 59(3):249. PubMed ID: 9722359
    [No Abstract]   [Full Text] [Related]  

  • 13. Adverse reactions to contrast media. Ionic and nonionic media and steroids.
    Lasser EC; Berry CC
    Invest Radiol; 1991 May; 26(5):402-3. PubMed ID: 1815541
    [No Abstract]   [Full Text] [Related]  

  • 14. Corticosteroid prophylaxis in patients at increased risk of adverse reactions to intravascular contrast agents.
    Doré CJ; Sidhu PS; Dawson P
    Clin Radiol; 1995 Mar; 50(3):198-9. PubMed ID: 7889718
    [No Abstract]   [Full Text] [Related]  

  • 15. Outcomes of corticosteroid prophylaxis for hypersensitivity reactions to low osmolar contrast media in high-risk patients.
    Jung JW; Choi YH; Park CM; Park HW; Cho SH; Kang HR
    Ann Allergy Asthma Immunol; 2016 Sep; 117(3):304-309.e1. PubMed ID: 27613465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Corticosteroid prophylaxis in contrast examinations.
    Sidhu PS; Dawson P
    Br J Hosp Med; 1997 Oct 1-14; 58(7):304, 306. PubMed ID: 9509046
    [No Abstract]   [Full Text] [Related]  

  • 17. Use of low-osmolar agents and premedication to reduce the frequency of adverse reactions to radiographic contrast media: a survey of the Society of Uroradiology.
    Cohan RH; Ellis JH; Dunnick NR
    Radiology; 1995 Feb; 194(2):357-64. PubMed ID: 7824710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Corticosteroid pretreatment and nonionic contrast media.
    Seymour R; Halpin SF; Hardman JA
    AJR Am J Roentgenol; 1995 Feb; 164(2):508-9. PubMed ID: 7840006
    [No Abstract]   [Full Text] [Related]  

  • 19. Repeat survey of current practice regarding corticosteroid prophylaxis for patients at increased risk for adverse reaction to intravascular contrast agents.
    Morcos SK
    Clin Radiol; 2005 Jun; 60(6):728. PubMed ID: 16038703
    [No Abstract]   [Full Text] [Related]  

  • 20. Corticosteroids in cholesterol emboli syndrome.
    Graziani G; Santostasi S; Angelini C; Badalamenti S
    Nephron; 2001 Apr; 87(4):371-3. PubMed ID: 11287784
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.